Agenus, Inc.

Name: Agenus, Inc.
Address: 3 Forbes Road, Lexington, MA, 02421, US
Telephone: +1 781-674-4200

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Agenus, Inc., Biotechnology company, 3 Forbes Road, Lexington, MA.

07/30/2021

July is Sarcoma Awareness Month!

Dr. Breelyn Wilky partners with Agenus on multiple sarcoma trials with balstilimab, zalifrelimab, and AGEN1181. Listen to her speak about the importance of sarcoma awareness and the benefit immunotherapy has had for patients with this disease.

Sarcoma Foundation of America, Inc.

06/03/2021

Agenus' collaboration with Bristol Myers Squibb will allow us to accelerate the advancement of our differentiated pipeline while also giving us greater optionality as we pursue the best development strategy for each individual asset.

investor.agenusbio.com/news-releases/…

05/21/2021

Like the rest of Agenus' differentiated pipeline, AGEN1777 is optimally designed to address an unmet need.

We are proud to collaborate with industry leader Bristol Myers Squibb to develop this Fc enhanced anti-TIGIT bispecific while continuing to advance our other innovations like our Fc enhanced anti-CTLA-4 AGEN1181 to serve patients with cancer and disrupt the IO space

https://investor.agenusbio.com/news-releases/news-release-details/agenus-and-bristol-myers-squibb-announce-exclusive-global

05/19/2021

Agenus and Bristol Myers Squibb entered into a collaboration with an aggregate value of up to $1.6B on AGEN1777, a product of our innovation engine.

Julie DeSander, VP Business Development & Alliance Management at Agenus, discusses how this collaboration will help advance the study of our innovations with the goal of helping cancer patients in need

https://investor.agenusbio.com/news-releases/news-release-details/agenus-and-bristol-myers-squibb-announce-exclusive-global

05/18/2021

Agenus and Bristol Myers Squibb enter into a collaboration with an aggregate value of up to $1.6B for development of Agenus’ differentiated anti-TIGIT bispecific AGEN1777. Click to learn more: https://bit.ly/3eV8Eh9

05/04/2021

Hear Agenus' Chief Medical Officer Dr. Steven O'Day's thoughts on the promises and challenges of combination immunotherapies at the World Vaccine Congress 2021 TODAY at 1pm!

Click to register and watch: https://www.terrapinn.com/conference/world-vaccine-congress-washington/index.stm

04/12/2021

Agenus' next-generation anti-CTLA-4 AGEN1181 is optimally designed with differentiated activity seen in the clinic.

Watch Agenus' CMO Steven O'Day, MD, discuss the power of this cancer & the exciting responses presented at !

Click to learn more: https://investor.agenusbio.com/news-releases/news-release-details/new-clinical-responses-agen1181-presented-aacr

Address

3 Forbes Road
Lexington, MA
02421

Telephone

+1 781-674-4200

Website

https://agenusbio.com/

Alerts

Be the first to know and let us send you an email when Agenus, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your business to be the top-listed Engineering Company in Lexington?